ACXP Average Annual Return Since 2021
Growth of $10,000.00
Without Dividends Reinvested Into ACXP


Also see:
ACXP YTD return
Compare ACXP average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 06/28/2021
End date: 01/27/2022
Start price/share: $6.24
End price/share: $3.58
Dividends collected/share: $0.00
Total return: -42.63%
ACXP Average Annual Return: -73.05%
Starting investment: $10,000.00
Ending investment: $5,737.00
Years: 0.58


ACXP average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Acurx Pharmaceuticals is a privately held clinical stage biopharmaceutical company focused on developing new antibiotics that address difficult to treat bacterial infections. Co.'s approach is to develop antibiotic candidates that could potentially block an entirely new molecular target, the DNA polymerase IIIC (Pol IIIC) enzyme, and its research and development pipeline includes early stage Pol IIIC antibiotic candidates that target other Gram-positive bacteria that are active parenterally, and potentially orally, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The ACXP average annual return since 2021 is shown above.

The Average Annual Return on the ACXP average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether ACXP average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ACXP average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree ACXP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Acurx Pharmaceuticals (ACXP) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ADGI Average Annual Return
ADIL Average Annual Return
ADMA Average Annual Return
ADMP Average Annual Return
ADPT Average Annual Return
ADTX Average Annual Return
ADUS Average Annual Return
ADVM Average Annual Return
ADXS Average Annual Return
AEMD Average Annual Return
More Healthcare companies »

 

ACXP Average Annual Return Since 2021 | www.AverageAnnualReturn.com | Copyright © 2021 - 2022, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.